MedTrace Logo

Topical Vitamin C for Treatment of Basal Cell Cancer

NCT04279535 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2021-11-02

No results posted yet for this study

Summary

Randomized coomparative trial of a 30% solution of ascorbic acid in 95% dimethylsulfoxide applied topically twice a day for 8 weeks vs 5% imiquimod cream in the treatment biopsy proven basal cell carcinomas inotherwise healthy adult patients. Outcome measure was biopsy proven resolution of the carcinoma.

Conditions

Interventions

DRUG

Topical Ascorbic Acid

Twice daily application of 300 microliters of 30% ascorbic acid solution with a small cuticle brush.

Sponsors & Collaborators

  • Center for Biomedical Research, Inc.

    lead INDUSTRY

Principal Investigators

  • Briant Burke, MD · CBR,Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-01
Primary Completion
2019-03-01
Completion
2019-06-01
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04279535 on ClinicalTrials.gov